Standard medical devices have a poor visibility in ultrasound imaging, creating a risk when carrying out medical interventions
Mediocre needle visibility leads to multiple insertion and repositioning efforts causing patient discomfort and an increased failure rate in vascular access and biopsy procedures
Sono-Coat® is a game-changing technology in situations “when precision counts”. Sono-Coat® catheters and needles are clearly visible in the image, allowing effortless location from any possible angle
The use of Sono-Coat® devices leads to an accurate diagnosis, reduced complication rates and better patient outcomes
Sono-Coat® provides excellent ultrasound visibility for catheters and needles, supporting clinicians in safely and accurately performing US-guided procedures
In deeper tissue structures the Sono-Coat® technology
enables precise targeting of objects
Patients benefit from safe, quick and first-time-right interventions
The Sono-Coat® technology is based on a coating matrix containing acoustically reflective microspheres. The reflective microspheres scatter the ultrasound waves in all directions
This scattering effect causes more ultrasound signal to be reflected to the probe, no matter the angle, resulting in a clear, sharp image on the screen
The NICE study published in GIE compares the ultrasound visibility of a Sono-Coat® needle and 8 commonly used echogenic needles. The Sono-Coat® needle outperformed (p<0.01) all other echogenic needles and was ranked number 1 in ultrasound visibility during a blind review by 60 interventional clinicians
The Sono-Coat® technology can be applied to a large variety of medical devices: the P-series coating system specifically developed for Polyurethane, Nylon, PEBAX, PEEK, PVC, and Polysilicon devices and the M-Series for Steel, Titanium, Nitinol and Ceramic based devices
Sono-Coat® is biocompatible, temperature resistant, and can be overcoated with lubricious, anti-microbial and anti-thrombogenic coatings without loss of echogenicity
Jasper van Weerd is responsible for overall management of the company, strategic alliances, funding and investor relations. He worked in the past in different academic projects in the US, Netherlands, Italy and the United Kingdom. From 2010 till 2014 Jasper was engaged with his PhD at the University of Twente, entitled, “Novel Biomedical Applications of Supported Lipid Bilayers”. His PhD has resulted in numerous public awards, authoring or co-authoring 11 internationally peer reviewed scientific papers, evolving into the launch of LipoCoat BV in 2016. Jasper holds Executive Directorships of in the LipoCoat Group as Chief Executive Officer
Fabian Stein leads the Business Development and Marketing from Sono-Coat. As part the LipoCoat Group he is responsible for Business Development and Global Sales for LipoCoat BV. He has more than 10 years’ of experience as a Researcher working in academic and Industry in the area of regenerative therapies and tissue engineering. He holds a Master of Science with a specialization in Medical cell biology from the University of Lübeck (GER) and is about to obtain his MBA with a specialization in General Management from Middlesex University of London (GBR).
Lee Ayres led the development of the Sono-Coat® technology. Lee is responsible for the improvement and upscaling of Sono-Coat BV’s coating technology platforms, managing customer sample tracks, business development and introducing technical innovations. Lee has built an extensive industry network focused on developing echogenic solutions for medical devices. Lee holds a Master's Degree in Chemistry from University of York and a PhD from the Radboud University of Nijmegen in Synthetic Polymer Chemistry.
Bram Pape leads the operational organization and is responsible for running Encapson’s day-to-day business and implements standardized business processes. He has a background in Project Management and R&D in the pharmaceuticaland medical industry at FeyeCon Carbon Dioxide Technologies, Océ Technologies and TMC. Bram holds a Master’s degree in Chemistry from Radboud University in Nijmegen and a PhD from the Eindhoven University of Technology in development of biomaterials for Regenerative Medicine and Drug Delivery.
Prague, Czech Republic – September 4-7, 2024
Lisbon, Portugal – September 14-18, 2024
Düsseldorf, Germany– November 11-14, 2024
